The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia.

Janet C. Mohle‐Boetani, Shiva K. Akula, Mark Holodniy, David Katzenstein, Gilsanz García

PubMed · 1992 · 29 citations · 15 references

Full text

Open access

Concepts

Abstract

DAPSONE IS A DIAMINOPHENYL sulfone indicated for the treatment of leprosy, to prevent malaria in travelers to en- demic regions, and to treat several dermatologic conditions, including dermatitis herpetiformis.Dapsone interferes with the production of folate from para-aminobenzoic acid (PABA).Because PABA is the main substrate for folate synthesis by Pneumocystis carinii, dapsone is used in the treatment of and prophylaxis against P carinii pneumonia in patients infected with the human immunodeficiency virus type 1.1-4Common side effects of dapsone therapy include the de- velopment of abnormal serum aminotransferase levels and hemolysis in patients deficient in glucose-6-phosphate dehy- drogenase (G6PD).5A severe dapsone hypersensitivity syn- drome, also known as the sulfone syndrome, has been reported sporadically in the literature.This is characterized by fever, rash, hemolytic anemia, atypical lymphocytosis, and acute (rarely fulminant) hepatic injury.6We report a case of the sulfone syndrome in a patient with the acquired immunodeficiency syndrome (AIDS) who was receiving dapsone as primary prophylaxis against P carinii pneumonia. Report of a CaseThe patient, a 35-year-old homosexual man with AIDS, was admitted to Stanford University Hospital with nausea, vomiting, and jaundice.He had been diagnosed with Kapo- si's sarcoma eight weeks before admission based on the results of a biopsy of violaceous lesions on his legs.The patient was being treated with trimethoprim-sulfamethoxazole as prophylaxis against P carinii pneumonia.In retrospect, the patient had noted a coated tongue, fevers, night sweats, and the skin lesions on his legs for a year.Six weeks before admission, he was randomly assigned to the dapsone (Mohle-Boetani

References

15